CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2021
Melbourne, Australia, 27 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Corporate Presentation - FY2021 Results
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Appendix 4E and Preliminary Financial Report
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
CLINUVEL Delivers Record Revenues and Profit
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Dividend/Distribution - CUV
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Appendix 4C & Activity Report
Melbourne, Australia, 29 July 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More
Appendix 3Y Change of Director's Interest Notice
Information or documents not available now must be given to ASX as...
Read More
Appendix 3Y Change of Director's Interest Notice
Information or documents not available now must be given to ASX as...
Read More
Appendix 3Y Change of Director's Interest Notice
Information or documents not available now must be given to ASX as...
Read More
Appendix 4C & Activity Report
Melbourne, Australia, 29 April 2021 CLINUVEL PHARMACEUTICALS LTD today announced its Appendix...
Read More
Appendix 3Y Change of Director's Interest Notice
CLINUVEL PHARMACEUTICALS LTD today released the attached Appendix 3Y which relates to...
Read More
Appendix 3Y Change of Director's Interest Notice
Information or documents not available now must be given to ASX as...
Read More
Operations Update Webinar
https://vimeo.com/516430955/8f3e88ca5chttps://vimeo.com/516430955/8f3e88ca5c
Read More
CLINUVEL Reports Tenth Consecutive Half Year Net Profit
KEY HIGHLIGHTS, HALF YEAR ENDED 31 DECEMBER 2020 Consolidated Entity Result Change...
Read More
Appendix 4D Half Year Report
Results For Announcement To The Market ($A’000) Revenues from continuing activities Increased...
Read More